What is Qpex Biopharma?
Qpex Biopharma is a medical company dedicated to combating infectious diseases. Established in 2018 and based in San Diego, California, the company focuses on developing novel therapeutic solutions for unmet medical needs in this critical area. Its strategic positioning within the biopharmaceutical landscape aims to address the growing global challenge of infectious disease outbreaks and resistance.
How much funding has Qpex Biopharma raised?
Qpex Biopharma has raised a total of $53M across 2 funding rounds:
Series A
$33M
Unspecified
$20M
Series A (2018): $33M, investors not publicly disclosed
Unspecified (2019): $20M led by Biomedical Advanced Research and Development Authority
Key Investors in Qpex Biopharma
Biomedical Advanced Research and Development Authority
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. government agency focused on public health security, likely investing in Qpex Biopharma to advance critical medical countermeasures against infectious diseases.
What's next for Qpex Biopharma?
The recent major strategic investment signals a pivotal phase for Qpex Biopharma, likely enabling the company to accelerate its research and development efforts, expand its clinical trial programs, and potentially scale its operational capacity. This infusion of capital is expected to propel Qpex Biopharma towards key milestones in its pipeline, further solidifying its role as a significant player in the infectious disease therapeutic market. The company's trajectory suggests a focus on advancing its lead candidates through regulatory pathways and preparing for potential commercialization.
See full Qpex Biopharma company page
